Page last updated: 2024-10-30

lorazepam and Pervasive Child Development Disorders

lorazepam has been researched along with Pervasive Child Development Disorders in 3 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"To review catatonia in autism spectrum disorders."2.52[Catatonia in autism spectrum disorders: review and case-report]. ( Dhossche, DM; Shettar, SM; van der Steen, LF, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhossche, DM1
van der Steen, LF1
Shettar, SM1
Dhossche, D1
Kellner, CH1
Consoli, A1
Gheorghiev, C1
Jutard, C1
Bodeau, N1
Kloeckner, A1
Pitron, V1
Cohen, D1
Bonnot, O1

Reviews

1 review available for lorazepam and Pervasive Child Development Disorders

ArticleYear
[Catatonia in autism spectrum disorders: review and case-report].
    Tijdschrift voor psychiatrie, 2015, Volume: 57, Issue:2

    Topics: Anticonvulsants; Benzodiazepines; Catatonia; Child; Child Development Disorders, Pervasive; Comorbid

2015

Other Studies

2 other studies available for lorazepam and Pervasive Child Development Disorders

ArticleYear
Pervasive refusal syndrome: A misnomer for catatonia.
    Asian journal of psychiatry, 2015, Volume: 18

    Topics: Catatonia; Child; Child Development Disorders, Pervasive; Diagnosis, Differential; Early Medical Int

2015
Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia.
    Journal of physiology, Paris, 2010, Volume: 104, Issue:6

    Topics: Adolescent; Catatonia; Child; Child Development Disorders, Pervasive; Fluoxetine; GABA Modulators; H

2010